Search for: "Purdue Pharma Inc."
Results 41 - 60
of 152
Sort by Relevance
|
Sort by Date
13 Oct 2016, 6:50 am
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
28 Sep 2016, 8:39 am
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
18 Sep 2016, 6:03 pm
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
11 Jun 2016, 4:04 am
Purdue Pharma Technologies, Inc. 51. [read post]
27 Mar 2016, 9:59 pm
Noonan -- Last Thursday, the Federal Circuit handed down its non-precedential decision in Purdue Pharma v. [read post]
24 Mar 2016, 10:43 am
Purdue Pharma L.P. [read post]
1 Feb 2016, 10:43 am
The appellant Purdue Pharma was represented by:GREGORY A. [read post]
1 Feb 2016, 8:11 am
By Dennis Crouch Purdue Pharma v. [read post]
31 Jan 2016, 7:57 pm
Laboratories Inc.; Purdue Pharmaceuticals L.P. [read post]
5 Nov 2015, 9:39 pm
Purdue Pharma L.P. et al. v. [read post]
6 Sep 2015, 8:26 am
The Purdue Frederick Company, Inc., Purdue and its top executives pleaded guilty to charges that it misled doctors and patients about the addictive properties of OxyContin and misbranded the product as "abuse resistant. [read post]
3 Sep 2015, 3:06 pm
EndoPharmaceuticals Inc., 438 F.3d 1123, 1134 (Fed. [read post]
25 Jun 2015, 5:00 am
Medtronic, Inc., ___ F. [read post]
9 Apr 2015, 5:00 am
Bard, Inc., 2015 WL 502010, at *4 (S.D.W. [read post]
29 Mar 2015, 9:59 pm
Purdue Pharma L.P. et al. v. [read post]
12 Feb 2015, 8:51 am
Purdue Pharma, Inc., 369 F. [read post]
10 Feb 2015, 1:01 pm
Purdue Pharma, L.P., 166 F.Supp.2d 546, 551-552 (E.D. [read post]
20 Jan 2015, 11:46 am
Purdue Pharma Co., 236 F. [read post]
12 Nov 2014, 10:15 am
Janssen and Teva file to protect Chicago disclosing trade secrets: Back in the summer, the city of Chicago commenced proceedings against several pharmaceutical companies, including Janssen, Purdue Pharma LP, Teva and Actavis alleging that they dishonestly marketed opioid painkillers including Oxycontin and Percocet for the treatment of common and non-cancer related chronic pain resulting in a reported public health crisis of addiction and abuse. [read post]
28 Oct 2014, 3:14 pm
Purdue Pharma L.P., 737 F.3d 908 (4th Cir. 2013). [read post]
